ReviewEuropean archives of psychiatry and clinical neuroscience2006
Do recent efficacy data on the drug treatment of acute bipolar depression support the position that drugs other than antidepressants are the treatment of choice? A conceptual review.
Review in European archives of psychiatry and clinical neuroscience, 2006. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers, 3 of them syntheses that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
15 citing papers in PubMed, 3 syntheses or guidelines pooled it.
- Long-term antidepressant treatment in bipolar disorder: meta-analyses of benefits and risks.Acta psychiatrica Scandinavica · 2008Pooled it
- [Problems of evidence-based medicine in psychopharmacotherapy: problems of evidence grading and of the evidence basis for complex clinical decision making].Der Nervenarzt · 2007Pooled it
- Evidence for beneficial effects of antidepressants on suicidality in depressive patients: a systematic review.European archives of psychiatry and clinical neuroscience · 2006Pooled it
- How Does Adding the DSM-5 Criterion Increased Energy/Activity for Mania Change the Bipolar Landscape?Frontiers in psychiatry · 2021Review
- Different neural responses to a moral valence decision task in unipolar and bipolar depression.ISRN psychiatry · 2013Article
- State of the art: treatment of bipolar disorders.CNS neuroscience & therapeutics · 2012Review
- Executive summary of the report by the WPA section on pharmacopsychiatry on general and comparative efficacy and effectiveness of antidepressants in the acute treatment of depressive disorders.European archives of psychiatry and clinical neuroscience · 2012Article
- General and comparative efficacy and effectiveness of antidepressants in the acute treatment of depressive disorders: a report by the WPA section of pharmacopsychiatry.European archives of psychiatry and clinical neuroscience · 2011Article
- Management of bipolar depression.Indian journal of psychological medicine · 2011Article
- Evidence-based medicine in psychopharmacotherapy: possibilities, problems and limitations.European archives of psychiatry and clinical neuroscience · 2010Article
- Is evidence sufficient for evidence-based medicine?European archives of psychiatry and clinical neuroscience · 2009Review
- [Core symptoms of depression. Effectiveness of antidepressant therapy].Der Nervenarzt · 2009Review
- Lithium: updated human knowledge using an evidence-based approach: Part I: Clinical efficacy in bipolar disorder.CNS drugs · 2009Review
- Effects of different antidepressant treatments on the core of depression.Dialogues in clinical neuroscience · 2008Article
- Bipolar II disorder : epidemiology, diagnosis and management.CNS drugs · 2007Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
This conceptual review summarises the results of relevant studies on antidepressants, mood stabilisers such as lithium and anticonvulsants, and second generation antipsychotics in the indication of bipolar depression. Based on methodological and clinical considerations, the position of antidepressants and the possible alternatives in this indication are reviewed very carefully. In addition the regulatory requirements for licensing a drug for the indication "short-term treatment of bipolar depression" are described.
Indexed as
Identifiers
16078087What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.